Company / Net Income
NOVAVAX INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$440.3M
FY2025
5-year range
-$1.7B / $440.3M
FY2021-FY2025
Trend
+334.8%
vs FY2024
Sector context
#23 of 216
Health Care
What the data says
Net Income changed +335% YoY in FY2025, a notable deviation from the 9-year average annual change of -15%.
Based on SEC 10-K filings.
$440M in FY2025. Top quartile in the Health Care sector.
Improved from -$545M to $440M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 216This company $440.3M Sector average $454.1M
▼
-3.0% below sector average
Key checks
Key Insights
- In FY2025, net income increased 334.8% year-over-year.
- Ranks #23 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $440.3M | +334.8% |
| FY2024 | -$187.5M | +65.6% |
| FY2023 | -$545.1M | -30.3% |
| FY2022 | -$418.3M | +76.0% |
| FY2021 | -$1.7B | -316.9% |
| FY2020 | -$418.3M | -127.6% |
| FY2019 | -$183.8M | +34.4% |
| FY2018 | -$280.0M | -78.4% |
| FY2017 | -$156.9M | -89.2% |
| FY2016 | -$82.9M | -59.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026